Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07565727 · ClinicalTrials.gov registry record

Cardiometabolic Disease and Substrate Metabolism

A clinical trial, sponsored by University of Tennessee Graduate School of Medicine.

Recruiting
Registry status
50
Enrollment target

NCT07565727 is a clinical trial that is actively recruiting participants, run by University of Tennessee Graduate School of Medicine. The registered enrollment target is 50 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07565727 is actively recruiting participants, sponsored by University of Tennessee Graduate School of Medicine.

RECRUITING
Registry status
50 participants
Enrollment target

Study Summary

This study's primary purpose is to determine the potential relationship between cardiometabolic disease, specifically insulin resistance (HOMA-IR), and maternal lipid oxidation.

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2025-12-10
Est. Completion 2027-08

What the Registry Record Tells You About NCT07565727

The ClinicalTrials.gov registry entry for NCT07565727 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Tennessee Graduate School of Medicine, which has 20 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT07565727 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT07565727 about?

NCT07565727 is a clinical study titled "Cardiometabolic Disease and Substrate Metabolism". This study's primary purpose is to determine the potential relationship between cardiometabolic disease, specifically insulin resistance (HOMA-IR), and maternal lipid oxidation.

What is the current status of trial NCT07565727?

This trial is currently recruiting. The enrollment target is 50 participants. The study started on 2025-12-10. Estimated completion is 2027-08.

Who is sponsoring clinical trial NCT07565727?

This trial is sponsored by University of Tennessee Graduate School of Medicine, which has 20 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.